Results 201 to 210 of about 240,659 (269)

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants. [PDF]

Clin Transl Sci
Yoo Y, Zahir H, Inaba S, Koo K, Garimella T, Abutarif M, Zheng M, Kamiyama E, Xu Y.   +8 more
europepmc   +1 more source

Cobalt Single‐Atom Nanozyme for Enhanced Intestinal Radioprotection and Tumor Radiosensitization via Bidirectional ROS Modulation

Advanced Science, EarlyView.
Orally administered, pH‐responsive Co‐SAN exerts dual functions: in the alkaline intestinal milieu, it scavenges reactive oxygen species (ROS) and suppresses the PI3K/AKT pathway and NETs formation, thus providing radioprotection; whereas in the acidic tumor microenvironment, it generates ROS and alleviates hypoxia, thereby enhancing radiosensitization.
Shengqi Yin, Junjie Li, Yishu Zou, Yang Liu, Yilin Zheng, Lu Yu, Wanying Zheng, Yajun Zou, Zehui Zhang, Tao Li, Peiqun Yin, Jianlin Zhang, Yuen Wu, Yi Ding   +13 more
wiley   +1 more source

Impact of Obesity on Propofol Dosing: Implications for Anesthetic Outcomes. [PDF]

Cureus
Sawires J, Chowdhury S, Girardin CR, Vega G, Weissman B, Soti V.   +5 more
europepmc   +1 more source

Liposomal encapsulation of L-arginine and L-citrulline enhances pharmacokinetics and therapeutic effects in a model of preeclampsia and fetal growth restriction. [PDF]

Sci Rep
van Kammen C, Brink M, Minnion M, Feelisch M, Schiffelers R, Lely T, Terstappen F.   +6 more
europepmc   +1 more source

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness. [PDF]

Clin Pharmacokinet
Wang Y, Bukkems LH, Ter Heine R, van Hasselt JGC, Koolen SLW, Hendrikx JJMA, Van der Hulle T, Kapiteijn E, Zwaveling J, Becker A, van den Heuvel MM, Theelen WSME, Oude Munnink TH, Smit EF, Guchelaar HJ, Moes DJAR.   +15 more
europepmc   +1 more source

Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat. [PDF]

Pharmacol Res Perspect
Sunnåker M, Leander J, Ericsson H.
europepmc   +1 more source

Associations of CYP2B6, CYP2C19, and CYP2D6 isoforms and phenoconversion with sertraline pharmacokinetics. [PDF]

PLoS One
Tapia-Alzuguren B, Canga-Espina C, Molero P, Aldaz A.   +3 more
europepmc   +1 more source

Pharmacokinetics of Oral Amoxicillin for the Treatment of Syphilis in Pregnancy. [PDF]

Open Forum Infect Dis
Dionne JA, Subramaniam A, Kahn M, Xue Y, Ryan KJ, Acosta EP.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics

Biochemical Pharmacology, 2014
Pharmacokinetics (PK) is the study of the time course of the absorption, distribution, metabolism and excretion (ADME) of a drug, compound or new chemical entity (NCE) after its administration to the body. Following a brief introduction as to why knowledge of the PK properties of an NCE is critical to its selection as a lead candidate in a drug ...
Jianghong, Fan, Inés A M, de Lannoy
openaire   +2 more sources

Lumping in Pharmacokinetics

Journal of Pharmacokinetics and Pharmacodynamics, 2005
Pharmacokinetic (PK) models simplify biological complexity by dividing the body into interconnected compartments. The time course of the chemical's amount (or concentration) in each compartment is then expressed as a system of ordinary differential equations.
Brochot, Céline, Toth, Janos, Bois, Frédéric Y.   +2 more
openaire   +4 more sources